ayush and pharmexcil

8/7/2019 Ayush and Pharmexcil

http://slidepdf.com/reader/full/ayush-and-pharmexcil 1/42

NAME : RENUKA PARESH JSEM-I

MBA(PHARMA)NIPER



y For the develping country like india it is not possible to invest billions of dollars on the R & D because thereare mare chances of success

y Some times the drugs are f ailed in phase ii and phaseiii and the whole money invested for that is wasted

y India is not able to discover a single block buster y molecule becauseof lack in R & D



y India is the land of biodiversity

y India has the great traditional knowledgeof ayurveda

and siddha

y India has literature like charak samhita , shushrutsamhita , and many ancient literature claiming to cure

incurabale killer disease



y But all the scripting is in sanskrit and no scientif icevidence is there to claim in the international martket

y Qc testing lab for the traditional medicines are very less in india

y W ork for novel natural molecule is at the emerging

stage



Deptt of A yushA yurveda, Siddha, Unani and Homeopathy

Department of Indian Systems of Medicine and

Homoeopathy (ISM&H) was created in March,1995

and re-named as (Department of Ayurveda, Yoga &Naturopathy, Unani, Siddha and Homoeopathy

(AYUSH) in November, 2003 with a view to

providing focused attention to development of Education & Research in Ayurveda, Yoga &

Naturopathy, Unani, Siddha and Homoeopathy

systems.



y Ayurveda (Sanskrit: ; yurveda, the

"science of life") or ayurvedic medicine is a system of

traditional medicine native to the Indian subcontinent and

practiced in other parts of the world as a form of alternative medicine

y In Sanskrit, the word ayurveda consists of the words yus,

meaning "longevity", and veda, meaning "related toknowledge" or "science".



y Evolving throughout its history, ayurveda remains an

influential system of medicine in South Asia.

y The earliest literature on Indian medical practice appearedduring the Vedic period in India.

y The S uruta S ahit and the Charaka S ahit were

influential works on traditional medicine during this era



y The US National Center for Complementary and AlternativeMedicine

y The European Federation for Complementary and Alternative

Medicine

y The European Ayurveda Association

y In 2009, the United States of America National Center for

Complementary and Alternative Medicine

y (NCCAM) of the National Institutes of Health expended $1.2million of its $123 million annual budget on ayurvedicmedicine-related research.



y

Patentsy In December 1993, the University of MississippiMedical

Center had a patent issued to them by United States Patentand Trademark Off iceon the use of turmeric for healing.

y The patent was contested by India's industrial researchorganization, Council for Scientif ic and Industrial Research(CSIR),

y on the grounds that traditional ayurvedic practitionerswere already aware of the healing properties of thesubstance for centuries, and that this prior art made thepatent a case of bio-piracy



.

y As a traditional medicine, many ayurveda productshave not been tested in rigorous scientif ic studies andclinical trials

y .In India, research in ayurveda is largely undertaken by the statutory body of the Central Government, the

Central Council for Research in A yurveda and Siddha(CCRAS), through a national network of researchinstitutes.



y A rishtha

y Vati

y Bhashmay Churna

y Avleha



y UNANI MEDICINE:- According to Unani medicine,management of any disease depends on the cause,

aggravating f actors, pathogenesis, pathology , andclinical manif estations.

Any cause and or f actor is countered by the power of body responsible to maintain health) the f ailing of which may lead to quantitatively or qualitatively dearangement of the normal equilibrium of akhlat(humors ) of body which constitute the tissues andorgans.



y Agasthy ar a great dravidian guru who is belived to b the f ather of the siddha sy stem

y

One of the most ancint medical wisdom of themankind

y Siddha vaidy am is the vast ocean of the scientif ic

knowledge and every drop of it is divine.



y Tamil is the language of the siddha vaidy am andproclaims that siddha wisdom has been origanatedfrom the parmshivam himself

y Siddha vaidy am can be def ined as the comprehansiveand scientif ic sy stem of medicine

y Which diagnsose all ty pes of human ailements by gauging the pulse of das nadis ( principal ten nerves)



y And cures the disease by aministering the elixir likemedicineof plants and natural resources.

y Neetumar unmukual

herbs prepared from the metals andthe 64 ty pes of the poisionous substances giving extracuring edge to the siddha sy stem

y

Siddha sy stem off ers treatment for 4400 ty pe of ailmentsincluding common cough and cold to killer disease likecancer and diabetes



y Siddha system classify disease in to three sections

y Saadhyam ± these are the disease which are cured withijn

the span of one mandalam ( 41 days)

y Klishta saadhyam ± for that one to three years are required

y Assadhyam ± siddha system will improve the condition of

the patients of assadhyam category



y Popular medical sciences including modern medicinesmay wilt and turn in eff ective before some of the so called incurable disease like asthma , psoriasis, hy per

tension, rheumatoid artharitis

y By adminstering properdose of siddha medicinepractioners may salvage people from the clutches of

killerdisease



y TKDL targets Indian Sy stems of Medicine, viz.,A yurveda, Unani, Siddha and Y oga available in publicdomain. This is being documented by sif ting and

collating the information on traditional knowledgefrom the existing literature existing in local languagessuch as Sanskrit, Urdu, A rabic, Persian and Tamil indigitized format, which will be available in f iveinternational languages which are English, German,

Spanish, French and Japanese.



Each Sloka is read and converted into a structuredlanguage using Traditional Knowledge ResourceClassif ication by subject (A yurveda, Unani, Siddha

or Y oga) experts. The codes are then f illed into thedata entry screen. The Slokas are also saved in thedatabase. The translated version of all the TKRCcodes is ported in the database. The abstraction is

done by the subject experts. The codes once saved inmeta data directory are converted in diff erentlanguages based on Unicode technology . Theformulations are presently



y TKDL acts as a bridge between formulations existingin local languages and a Patent Examiner at a globallevel, since the database will provide information onmodern as well as local names in a language andformatunderstandable to Patent Examiners. It isexpected that the issue of the gap on lack of access to prior art traditional knowledge shall get addressed



Set up by Ministry of Commerce on 12 May, 2004

Objective : To give Focused Attention to Pharma Exports

Supported by : All Major Pharma Associations

IDMA,BDMA,OPPI,IPA

Rs. 3 Crores Contribution by Government of AndhraPradesh. H.O. at Hyderabad , R.O. at Mumbai & New

Delhi

-Autonomous in Nature

-Government nominees on the Board

-Provides commercially useful information & Assistance

-Professional advise in technology related matters



R ole of Pharmexcil:-Organize visits of Delegations to ExploreOverseas Markets

-Participation in Trade Fairs / Exhibition-Take up problems of members with theGovernment Agencies-Build a statistical base & provide data on Exports



Bulk drug

s/ drug i

nterm

ediates

Drug formulations

Herbals / Ayurv edics / Homeopathic /Unani

Medicinal Plants

Bio-tech / Biological products

Diagnostics and Surgicals

Neutraceuticals

Collaborativ e /contract research

Clinical trials

Pharma consultancy services etc.`



Delegations/BSM to Abroad :

1. Argentina, Chile, Peru Aug¶08

2. Uzbekistan, Turkmenistan, Kyrgyztan Feb

093. Herbal Delegation to Brussels & EU countries Oct

09

Exhibitions Abroad:

CPhI Japan 9th-11th April 2008, Supply Side East, USA28th-30th April 2008, MediPharma Expo, Vietnam 21st-24th May 2008, CPhI, South America, Brazil 19th ± 21stAug 2008, Apteka, Russia October 2008, CPhiWorldwide, Germany 30th ± 2nd Oct 2008



CphI India, Mumbai 28th ± 30th November -Postponed

Informex 2009 USA, Jan 2009, Arab Health 2009 Dubai,

Jan 2009, Asia Pharma Expo, Jan 2009Seminars & Work Shops Completed

Hyderabad - April 2008, Mumbai- June 2008, Delhi ± July 2008, Bhubaneswar ± Nov 2008

Kolkata, Ahmedabad, Lucknow, Baroda, Dehradun ± Proposed 2009

Deptt of Ayush proposed Pharmexcil to have 3international events in 2009-10



y

NMPB: Various schemes for Cultivation of MAPs,preparation of Project Reports, Documentary Filmpreparation, Establishment & maintenance of HerbalGardens & Nursery etc.

y

(evaluated cost of about Rs. 630 lacs for 11th 5 Yr plan.

Nurseries 4 ± 20 Lacs

Cultivation 20% - 75% (depending on the species of

cultivation selected)Post Harvestment Management 5 Lacs (50%-100%)

Processing & Value addition 10- 50 lacs @ 25- 50%

Further details available on the NMPB web site



y APEDA : 50% of analytical charges are reimbursed for testing Egg powder, Honey & Grapes.

Vishesh Krishi Upaj Yojana: Duty Credit at 5% of the

FOB Value

Backward Regions Grant Fund: Grant of Rs 10 crore per District (total 250 Districts) for providing technicalassistance, office infra structure, training, conduct of

surveys, etc at Panchayat level.

y For new ideas:www.tdb.gov.in



DRUG DISCOBERY IN INDIA IS DIFFICULT DUE TO THE LIMITEDRESAOURSCES AND, R & D OF PHARMACEUTICAL IS VERY

EXPENSIVE , DUE TO LONGER DRUG DISCOVERY PIPELINE ANDSUCCESS RATE IS AMPLE

INDIA HAS GREAT ANCIENT WEALTH OF AYURVEDA AND SIDDHA THAT CLAIMS TO CURE KILLER DISEASE BUT ONLY LACUNAE ISAVAILABILTY OF SCIENTIFIC EVIDENCE FOR INTERNATIONAL

MARKET.

IF WE COMBINE OUR TRADITONAL KNOWLEDGE AND SCIENTIFCRESOURCES THEN IT WILL BE GREAT BOON FOR INDIA.

ayush and pharmexcil

Documents